ALBIREO PHARMA, INC. Calendario grafico Albireo Pharma, Inc.
ed9e24.hV5vpeFFPVEsKKj67n_JKWxnMQ9p9Vb-wvf5X7rxsvw.7jouz5IDbXxKd86bnRL-ShQrCWEKomCUo8eWb-Wa5LD1DxuWhg1HJEJ6-Q~9b7f648e0f439160f1d1a75d87424b97
Prossimi eventi su Albireo Pharma, Inc.
Nessun evento disponibile
Eventi passati su Albireo Pharma, Inc.
| 15/11/2022 11:20 | Jefferies London Healthcare Conference |
| 08/11/2022 22:30 | Q3 2022 Presentazione dei risultati |
| 08/11/2022 | Q3 2022 Pubblicazione dei risultati Dopo chiusura |
| 07/11/2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37254 |
| 07/11/2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37608 |
| 07/11/2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 850 |
| 07/11/2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37939 |
| 07/11/2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37273 |
| 06/11/2022 20:10 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 865 |
| 06/11/2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Meeting : 37733 |
| 18/10/2022 16:30 | H.C. Wainwright Hepatitis B Virus (HBV) Conference |
| 15/10/2022 20:00 | NASPGHAN Meeting |
| 15/10/2022 18:00 | NASPGHAN Meeting - Abstract Number : 547 |
| 14/10/2022 19:45 | NASPGHAN Meeting |
| 14/10/2022 18:00 | NASPGHAN Meeting - Abstract Number : 301 |
| 13/10/2022 23:00 | NASPGHAN Meeting - Abstract Number : 70 |
| 11/10/2022 14:30 | Bylvay Phase 3 Trial Results Call |
| 28/09/2022 14:30 | Guggenheim Therapeutics Conference |
| 13/09/2022 14:30 | Baird Global Healthcare Conference |
| 12/09/2022 16:30 | Morgan Stanley Global Healthcare Conference |
Più eventi
